PW Medtech Group Limited (HKG:1358)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Infusion Set	207.64M	286.65M	286.65M	248.49M	271.40M
Infusion Set Growth	-27.56%	0%	15.35%	-8.44%	9.72%
Blood Purification	611.79M	482.26M	482.26M	288.34M	-
Blood Purification Growth	26.86%	0%	67.26%	-	-
Regenerative Medical Biomaterials	4.07M	-	-	-	-
Total	823.51M	768.90M	768.90M	536.83M	271.40M
Total Growth	7.10%	0%	43.23%	97.80%	9.72%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	635.96M	643.93M	606.23M	505.62M	-
China Growth	-1.24%	6.22%	19.90%	-	-
India	55.95M	39.67M	24.47M	21.47M	-
India Growth	41.04%	62.15%	13.97%	-	-
America(Excluding U.S)	26.45M	21.17M	13.52M	7.56M	-
America(Excluding U.S) Growth	24.95%	56.56%	78.84%	-	-
Africa Region	29.27M	18.11M	6.83M	-	-
Africa Region Growth	61.58%	165.37%	-	-	-
Other Asia Countries	65.03M	36.17M	-	-	-
Other Asia Countries Growth	79.79%	-	-	-	-
Others	10.85M	9.85M	24.04M	2.18M	-
Others Growth	10.16%	-59.03%	1005.29%	-	-
Mainland China, including Hong Kong (HK)	-	-	-	-	271.40M
Mainland China, including Hong Kong (HK) Growth	-	-	-	-	9.72%
Total	823.51M	768.90M	675.08M	536.83M	271.40M
Total Growth	7.10%	13.90%	25.75%	97.80%	9.72%

Source: S&P Global Market Intelligence.